Mar 03, 2021 / 06:20PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good afternoon, and welcome to the Merck session of Cowen's 41st Annual Health Care Conference. We're very pleased to have Merck back with us again this year. Representing the company is Frank Clyburn, who is Chief Commercial Officer; as well as Peter Dannenbaum, who is the global Head of Investor Relations. So we appreciate you both being here with us today.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystMerck had a solid year in 2020. Frank, as you peer into 2021, what do you see as the pushes and pulls to the year? What do you think will maybe go better than expected? What do you think could be a little bit more challenging?
Franklin K. Clyburn - Merck & Co., Inc. - Chief Commercial Officer & Executive VP
Sure, Steve. So thanks for having us, and it's great to be here this afternoon. As we look into 2021, we first remain,